Covered recipient · General Payments record
JERRI D ROBERTSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$988.04
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $189.06 | 12 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $68.42 | 4 |
| Acerta Pharma LLC | $28.17 | 2 |
| Amgen Inc. | $21.45 | 1 |
| PFIZER INC. | $14.50 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.44 | 1 |
| Lilly USA, LLC | $14.41 | 1 |
| Otsuka America Pharmaceutical, Inc. | $14.12 | 1 |
| Seqirus USA Inc | $13.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $16.80 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998638821 | CMS |
| AbbVie Inc. | $17.98 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998638827 | CMS |
| AbbVie Inc. | $16.57 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998638833 | CMS |
| AbbVie Inc. | $17.07 | 05/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998638839 | CMS |
| Amgen Inc. | $21.45 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020600375 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.68 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1024991819 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.49 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025065049 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14.44 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996593009 | CMS |
| Lilly USA, LLC | $14.41 | 03/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031708507 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.12 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014748077 | CMS |
| PFIZER INC. | $14.50 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050346323 | CMS |
| Seqirus USA Inc | $13.55 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1021353669 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.